NASDAQ: BMEABiomea Fusion Inc Stock Ownership - Who owns Biomea Fusion?
Insider buying vs selling
Have Biomea Fusion Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Franco Valle | Chief Financial Officer | 2023-11-30 | 1,345 | $3.78 | $5.09kBuy |
| A2a Pharmaceuticals Inc | 10% Owner | 2023-06-01 | 50,000 | $34.56 | $1.73MSell |
| A2a Pharmaceuticals Inc | 10% Owner | 2023-05-31 | 75,000 | $33.81 | $2.54MSell |
| Franco Valle | Chief Financial Officer | 2023-05-31 | 4,273 | $3.78 | $16.16kBuy |
| A2a Pharmaceuticals Inc | 10% Owner | 2023-05-12 | 25,000 | $33.84 | $846.00kSell |
| A2a Pharmaceuticals Inc | 10% Owner | 2023-05-09 | 150,000 | $34.51 | $5.18MSell |
| A2a Pharmaceuticals Inc | 10% Owner | 2023-05-08 | 100,000 | $33.99 | $3.40MSell |
BMEA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BMEA insiders and whales buy or sell their stock.
BMEA Shareholders
What type of owners hold Biomea Fusion Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 14.92% | 5,355,867 | $57.52M | Institution |
| Thomas Andrew Butler | 13.03% | 4,676,078 | $50.22M | Insider |
| Sotirios Stergiopoulos | 12.26% | 4,400,000 | $47.26M | Insider |
| Bihua Chen | 9.95% | 3,570,872 | $38.35M | Insider |
| Cormorant Asset Management LP | 9.95% | 3,570,872 | $38.35M | Institution |
| A2a Pharmaceuticals Inc | 9.75% | 3,500,000 | $37.59M | Insider |
| Laurion Capital Management LP | 7.62% | 2,736,367 | $29.39M | Institution |
| Blackrock Inc | 6.01% | 2,156,342 | $23.16M | Institution |
| Baker Bros Advisors LP | 5.88% | 2,108,949 | $22.65M | Institution |
| Janus Henderson Group PLC | 4.79% | 1,718,245 | $18.45M | Institution |
BMEA vs Biotech Stocks
Biomea Fusion Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.